Illumina acquires Fluent BioSciences to accelerate single|cell ...

Illumina acquires Fluent BioSciences to accelerate single-cell ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has ...

Illumina buys Fluent BioSciences for single-cell analysis tech

The DNA sequencing giant has now acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics research.

Illumina acquires Fluent BioSciences to accelerate single-cell ...

Illumina, a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences.

Illumina acquires Fluent BioSciences to accelerate single-cell ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent ...

Illumina acquires Fluent BioSciences to boost single-cell analysis

US-based DNA sequencing technologies provider Illumina has completed the acquisition of Fluent BioSciences, which develops a highly differentiated single-cell ...

Illumina Acquires Fluent BioSciences Single-Cell Technology

July 9, 2024 | Illumina has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. Fluent ...

Illumina acquires Fluent BioSciences to accelerate single-cell ...

Illumina (ILMN) acquires Fluent BioSciences to enhance multiomics capabilities with scalable, cost-effective single-cell analysis tech.

Wouter Meuleman on LinkedIn: Illumina acquires Fluent ...

Illumina Inc (NASDAQ:ILMN) acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics research for an undisclosed consideration.

Toumy G. on LinkedIn: Illumina acquires Fluent BioSciences to ...

In a surprising move (at least to me) Illumina acquires single cell analysis company Fluent Biosciences. It will be interesting what dynamic ...

Product Sheets Archives - Fluent BioSciences

Illumina Acquires Fluent BioSciences to Accelerate Single-cell Analysis and Discovery ... Fluent PIPseq 3′ Single Cell RNA Kits. Download · Fluent BioSciences.

Company - Fluent BioSciences

Illumina Acquires Fluent BioSciences to Accelerate Single-cell Analysis and Discovery ... Cell Diagnostics (acquired by Bio-Techne), and Principia. Before ...

Illumina Buys Fluent BioSciences - Nasdaq

... Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology ... cell method will accelerate our ability ...

Illumina acquires Fluent BioSciences to bolster single-cell analysis ...

... single-cell method will accelerate their ability to deliver full multiomics solutions for their customers. Illumina will remain an open NGS ...

Illumina sees stock spike after acquisition of Fluent BioSciences

Illumina has seen a sharp rise in stock price after acquiring the single-cell analysis company in a bid to expand its RNA sequencing ...

Illumina buys Fluent BioSciences to strengthen foothold in single ...

Illumina buys Fluent BioSciences to strengthen foothold in single-cell analysis ... A few weeks after completing its divestment of cancer test ...

Illumina acquires Fluent BioSciences - LabPulse.com

Illumina announced that it has acquired Fluent BioSciences, a developer of single-cell analysis technology.

Illumina acquires Fluent BioSciences - 2024-07-09 - Crunchbase

illumina.com — Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base · Unlock even more features ...

Illumina Acquires Fluent BioSciences Single-Cell Technology

... single-cell method will accelerate our ability to deliver full multiomics solutions for our customers.” Fluent's single-cell analysis ...

Illumina boldly acquires Fluent Bio weeks after Grail divestiture

on July 9 with cash on hand, just a fortnight after freeing itself of Grail Inc. Fluent's single-cell analysis technology expands Illumina's ...

Illumina buys Fluent Biosciences, adding single-cell analysis tech

Illumina has bought Fluent Biosciences to add single-cell analysis technology to its portfolio, the company said Tuesday.